Related Experiment Video
Updated: Apr 8, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
A Shot in the Dark: Unprecedented Complete Radiologic Response of Metastatic Prostate Cancer to Single-Dose Androgen
Rohit S Deshpande1, Puneet Ahluwalia1
1Robotic Surgery and Uro-Oncology, Medanta - The Medicity, Gurugram, Gurugram, IND.
Abstract:
Androgen deprivation therapy (ADT) is a well-established treatment strategy for metastatic prostate cancer, aimed at reducing tumor burden and alleviating symptoms. Although ADT is a cornerstone in managing prostate cancer, complete radiological regression of metastatic disease, with a single dose of ADT, has not been previously reported. We present an exceptional case of a patient with metastatic prostate cancer who achieved a complete radiological response to ADT, highlighting an extraordinary therapeutic outcome.

